[Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma].


Journal

[Rinsho ketsueki] The Japanese journal of clinical hematology
ISSN: 0485-1439
Titre abrégé: Rinsho Ketsueki
Pays: Japan
ID NLM: 2984782R

Informations de publication

Date de publication:
2020
Historique:
entrez: 8 8 2020
pubmed: 8 8 2020
medline: 25 9 2020
Statut: ppublish

Résumé

A 56-year-old woman was referred to our hospital with symptoms of swelling, purpura, and pain in her limbs. Prior to referral, bleeding in her limbs had spontaneously appeared and disappeared several times. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were prolonged, and the factor II level was 17%. The plasma-mixing test indicated lupus anticoagulant (LA), which was confirmed using aPTT-LA and dilute Russell's viper venom time (dRVVT). Therefore, she was diagnosed with lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS). During screening for underlying disorders, chest computed tomography (CT) revealed a retrosternal mass. Biopsy was not performed because the administration of freshly frozen plasma failed to correct her coagulopathy. Prednisolone (PSL) treatment (1 mg/kg) was initiated, which normalized the coagulation tests. The retrosternal mass also disappeared. PSL was tapered without LAHPS recurrence; however, the follow-up CT revealed systemic lymphadenopathy. Follicular lymphoma was diagnosed using lymph-node biopsy. Considering the subsequent LAHPS recurrence, six cycles of bendamustine + rituximab were administered. Complete response with no LAHPS recurrence was observed at the time of drafting this report. LAHPS is rare and distinct from antiphospholipid syndrome because it can cause severe bleeding. Underlying disorders should be evaluated in cases of LAHPS.

Identifiants

pubmed: 32759560
doi: 10.11406/rinketsu.61.745
doi:

Substances chimiques

Lupus Coagulation Inhibitor 0

Types de publication

Case Reports Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

745-749

Auteurs

Daisuke Koyama (D)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Ryo Hanajiri (R)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Takeshi Kanematsu (T)

Department of Clinical Laboratory, Nagoya University Hospital.

Rie Ito (R)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Satomi Yamamoto (S)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Naoto Imoto (N)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Nobuaki Suzuki (N)

Department of Transfusion Medicine, Nagoya University Hospital.

Shingo Kurahashi (S)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Isamu Sugiura (I)

Division of Hematology and Oncology, Toyohashi Municipal Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH